Adenoid Cystic Carcinoma

Also known as: Adenoid Cystic Carcinomas / ADCC / Adenoid cystic carcinoma (morphologic abnormality) / Carcinoma, Adenoid Cystic / Cylindroma / Cylindroma (morphologic abnormality) / Antibody-mediated lympholysis (function) / Antibody-dependent cellular cytotoxicity (function) / Antibody-Dependent Cell Cytotoxicity

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB13982Lutetium Lu-1770Recruiting1
DB01590Everolimus1Completed1
DB00480Lenalidomide1Completed1
DB06192Nimotuzumab1Unknown Status1
DB12006Osugacestat1Recruiting1
DB04974Rimiducid1Active Not Recruiting1
DB14922Tislelizumab1Completed1
DB18052VMD-9281Recruiting1
DB12001Abemaciclib1 / 2Recruiting1
DB15279CB-1031 / 2Recruiting1
DB15279CB-1031 / 2Terminated1
DB00002Cetuximab1 / 2Unknown Status1
DB09078Lenvatinib1 / 2Recruiting1
DB09037Pembrolizumab1 / 2Recruiting1
DB06626Axitinib2Completed1
DB00188Bortezomib2Completed1
DB00958Carboplatin2Active Not Recruiting1
DB00958Carboplatin2Withdrawn1
DB00002Cetuximab2Recruiting1
DB00515Cisplatin2Completed1
DB00380Dexrazoxane2Completed1
DB05928Dovitinib2Completed2
DB00997Doxorubicin2Completed1
DB16047Elraglusib2Active Not Recruiting1
DB16047Elraglusib2Withdrawn1
DB01590Everolimus2Completed1
DB00544Fluorouracil2Recruiting1
DB00619Imatinib2Unknown Status1
DB06186Ipilimumab2Active Not Recruiting1
DB00762Irinotecan2Recruiting1
DB09078Lenvatinib2Active Not Recruiting1
DB09078Lenvatinib2Recruiting1
DB00650Leucovorin2Recruiting1
DB13982Lutetium Lu-1772Completed1
DB13982Lutetium Lu-1772Not Yet Recruiting2
DB16778Lutetium Lu-177 vipivotide tetraxetan2Not Yet Recruiting1
DB00220Nelfinavir2Completed1
DB09035Nivolumab2Active Not Recruiting1
DB12006Osugacestat2Completed1
DB09037Pembrolizumab2Completed1
DB09037Pembrolizumab2Recruiting1
DB08896Regorafenib2Active Not Recruiting1
DB14765Rivoceranib2Completed1
DB14765Rivoceranib2Unknown Status2
DB01268Sunitinib2Completed1
DB00755Tretinoin2Completed1
DB06334Tucidinostat2Completed1
DB12737BrontictuzumabNot AvailableCompleted1